No Adjustment of Conversion Price. No adjustment in the Series A-1 Conversion Price or the Series A-2 Conversion Price, as applicable shall be made as the result of the issuance or deemed issuance of Additional Shares of Common Stock if the Corporation receives written notice from the Required Holders, with respect to the Series A-1 Conversion Price, or the holders of a majority of the Series A-2 Preferred Stock, with respect to the Series A-2 Conversion Price, in either case agreeing that no such adjustment shall be made as the result of the issuance or deemed issuance of such Additional Shares of Common Stock.
Appears in 11 contracts
Sources: Contribution and Exchange Agreement (RiverRoad Capital Partners, LLC), Contribution and Exchange Agreement (Steinberg Michael), Contribution and Exchange Agreement (Sagrera Ricardo A.)
No Adjustment of Conversion Price. No adjustment in the Series A-1 1 Conversion Price or the Series A-2 Conversion Price, as applicable shall be made as the result of the issuance or deemed issuance of Additional Shares of Common Stock if the Corporation receives written notice from the Required Holders, with respect to the Series A-1 Conversion Price, or the holders of at least a majority of the then outstanding shares of Series A-2 1 Preferred Stock, with respect to the Series A-2 Conversion Price, in either case Stock agreeing that no such adjustment shall be made as the result of the issuance or deemed issuance of such Additional Shares of Common Stock.
Appears in 2 contracts
Sources: Merger Agreement (Zynerba Pharmeceuticals, Inc.), Merger Agreement (Zynerba Pharmeceuticals, Inc.)
No Adjustment of Conversion Price. No adjustment in the Series A-1 A Conversion Price or the Series A-2 Conversion Price, as applicable Price shall be made as the result of the issuance or deemed issuance of Additional Shares of Common Stock if the Corporation receives written notice from the Required Holders, with respect to the Series A-1 Conversion Price, or the holders of a majority at least fifty percent (50%) of the Series A-2 then outstanding shares of Preferred Stock, with respect to the Series A-2 Conversion Price, in either case Stock agreeing that no such adjustment shall be made as the result of the issuance or deemed issuance of such Additional Shares of Common Stock.
Appears in 1 contract